Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Opus
KANTREXIL SUSPENSION KANTREXIL TABLETS SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): KANTREXIL SUSPENSION KANTREXIL TABLETS COMPOSITION Each tablet and each 5 mL suspension contains: Kanamycin sulphate equivalent to 100 mg kanamycin Aminopentamide hydrogen sulphate 0,033 mg Pectin 25 mg Bismuth subcarbonate 250 mg Activated attapulgite 500 mg Preservatives: (In suspension) Methylparaben 0,1% m/v Propylparaben 0,02% m/v Sodium benzoate 0,1% m/v Suspension contains TARTRAZINE PHARMACOLOGICAL CLASSIFICATION A 11.9.1 Antidiarrhoeals in combination with anti-infective agents PHARMACOLOGICAL ACTION Kantrexil has antibiotic, adsorbent, protective and demulcent properties. INDICATIONS Treatment of specific and non-specific gastro-enteritis. CONTRA-INDICATIONS Hypersensitivity to any of the ingredients, or to other amino-glycoside antibiotics. Patients with glaucoma, myasthenia gravis and in patients with prostatic hypertrophy. WARNINGS A consequence of diarrhoea may be fluid and electrolyte depletion, and rehydration therapy may be necessary, especially in infants and young children. Kantrexil Suspension contains tartrazine which may cause allergicmtype reactions (including bronchial asthma) in certain susceptible individuals. Although the overall incidence of Tartrazine sensitivity in the general population is thought to be low it is frequently seen in patients who also have aspirin sensitivity. DOSAGE AND DIRECTIONS FOR USE Suspension Children 1-6 years: 1 medicine measure (5 mL) every 4-6 hours Children 6-12 years: 2 medicine measures (10 mL) every 4-6 hours Adults: 3 medicine measures (15 mL) every 4-6 hours. The suspension should be thoroughly shaken before the administration of each dose. Tablets Tablets Adults: 3 tablets every 6 hours. In severe cases, this dose may be initially administered every 4 hour Read the complete document